Crohn's disease (CD) is a type of inflammatory bowel disease (IBD). In this condition, the immune system mistakenly attacks healthy bacteria in the GI tract.
Crohn's disease is more frequent in women than men, as estimated by the Centers for Disease Control and Prevention.
Know more about the Crohn's disease pathophysiology, etiology, and manifestation through DelveInsight's newsletter. The newsletter covers Crohn's disease epidemiological analysis and the population that gets most affected by the disease.
The newsletter provides a brief overlay of the current treatment practices, prevailing unmet needs, and the upcoming ones and Crohn's disease clinical trials investigating different therapeutic agents.
Learn more about the latest happenings in the Crohn's disease market landscape, collaborations and funding taking place, research and development, and market trend in the next decade.
Download the newsletter by simply filling up the form towards the right and get the newsletter directly delivered into your mailbox.
Subscribe and stay in the loop.
Map the latest updates on Crohn's disease treatment landscape through our blog.
Also, do check out our infographics section for more information on Crohn's disease market outlook
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Epidemiological trends
- Treatment approaches
- Clinical trials
- Pipeline drugs
- Market insights
- Top conferences
- News front
- Support from International organizations
- Unmet needs